Upcoming Webinar – Incorporating R into your Clinical Legacy Workflows
Mike Stackhouse, Chief Innovation Officer, was a guest on the RStudio Blog and wrote about an upcoming joint webinar Incorporating...
Atorus / GSK Package Release
In August 2020, Atorus and GSK entered a unique relationship. As two separate organizations both committed to the advancement of...
Highlighting SAS Chunks in RMarkdown
SAS is a major player in the clinical trial world, and as R enthusiasts here at Atorus, finding ways that...
Building a ggplot2 Theme
Several graphs are created within the clinical trial space for a single submission. While there is a lot of domain...
Obstacles and Opportunities With Open Source Vlog
Chief Innovation Officer Michael Stackhouse addresses closed-source-mentality obstacles, the opportunities the open source community creates, and how the drug development...
Benefits of R Language Vlog
Is there a benefit to using R language in drug development in particular? Chief Innovation Officer Michael Stackhouse describes how...
Benefits of Open Source Vlog
Atorus Research Chief Innovation Officer Michael Stackhouse explains the benefits of using open source in the drug development industry.
Tplyr Version 0.2.2 Released
It’s been about 2 months since we initially released Tplyr out to CRAN, and in the time since then we’ve...
Open Source and Collaboration
The rapid development of open source technology is consistently amazing. The landscape has changed so dramatically in just the last...
Multilingual Markdown with R and Python Using Reticulate
Atorus Research presented their Multilingual Markdown workshop at R/Pharma last week. In this workshop, they presented the interoperability between Python...